Recalibrating Pathological Brain Network Connectivity using Real-time fMRI Neurofeedback among Frontline Healthcare Workers with Post-Traumatic Stress Disorder (PTSD)

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 475471

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2022
  • Known Financial Commitments (USD)

    $77,083.46
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Lieberman Jonathan
  • Research Location

    Canada
  • Lead Research Institution

    McMaster University
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Health Personnel

Abstract

Throughout the COVID-19 pandemic, frontline healthcare workers have faced continuous exposure to highly intense and emotional situations, such as witnessing death and suffering. As a result, 1 in 4 Canadian healthcare workers are estimated to have developed symptoms of post-traumatic stress disorder (PTSD) during the pandemic. Further compounding this problem is that the treatments currently offered for PTSD are often ineffective for many patients and may leave up to 40% of healthcare workers with persistent symptoms. Addressing this treatment gap is an urgent societal need as there currently exists immense suffering among the many frontline healthcare workers who have selflessly served Canadians throughout the COVID-19 pandemic. In response to this urgent societal need, a new technology-based approach to PTSD treatment called neurofeedback has emerged as a promising solution. Neurofeedback is a non-invasive brain-computer-interface that allows individuals to search for appropriate cognitive strategies to voluntarily restore healthy brain function and thereby reduce PTSD symptoms. Indeed, early findings have shown neurofeedback to be effective in reducing PTSD symptoms within certain populations (i.e., military members and veterans). However, healthcare workers have endured unique trauma experiences during COVID-19 and the effectiveness of neurofeedback for reducing PTSD symptoms in this population has yet to be studied. Results from this study may inform future clinical trials of neurofeedback and could lead to a novel PTSD treatment for both healthcare workers and other trauma-exposed populations.